Symptom distress in patients receiving Phase I chemotherapy with taxol
Strauman, J.J.
Oncology Nursing Forum 13(5): 40-43
1986
ISSN/ISBN: 0190-535X PMID: 2875441 Document Number: 273985
Document emailed within 1 workday
Related Documents
1989: Predicting distress in children receiving chemotherapy Oncology 3(5): 68-69Kleinman, L.; Benjamin, K.; Viswanathan, H.; Mattera, M.Stoeckl.; Bosserman, L.; Blayney, D.W.; Revicki, D.A. 2012: The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment Care and Rehabilitation 21(7): 1255-1266
Bhat, N.; Perera, P.Y.; Carboni, J.M.; Blanco, J.; Golenbock, D.T.; Mayadas, T.N.; Vogel, S.N. 1999: Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression Journal of Immunology 162(12): 7335-7342
Wickham, R.S.; Rehwaldt, M.; Kefer, C.; Shott, S.; Abbas, K.; Glynn-Tucker, E.; Potter, C.; Blendowski, C. 1999: Taste changes experienced by patients receiving chemotherapy Oncology Nursing Forum 26(4): 697-706
1996: Chemotherapy of ovarian and breast cancer with Taxol Deutsche Medizinische Wochenschrift 121(50 Suppl): 1-12
Rogez, E.; Thiais, S. 1995: Care and monitoring of patients receiving home chemotherapy Revue de l'Infirmiere 3: 37-40
Grem, J.L.; Tutsch, K.D.; Simon, K.J.; Alberti, D.B.; Willson, J.K.; Tormey, D.C.; Swaminathan, S.; Trump, D.L. 1987: Phase I study of taxol administered as a short i.v. infusion daily for 5 days Cancer Treatment Reports 71(12): 1179-1184
Robinson, J.P.; Avi-Itzhak, T.; McCorkle, R. 2007: Psychometric properties of the Male Urogenital Distress Inventory (MUDI) and Male Urinary Symptom Impact Questionnaire (MUSIQ) in patients following radical prostatectomy Urologic Nursing 27(6): 512-518
Mulder, H.; Hackeng, W.H.; vd Lely, A.J.; Siersema-Smallegange, M. 1990: Change of serum calcitonin in patients receiving glucocorticoids: an acute phase study Netherlands Journal of Medicine 36(5-6): 288-290
Iconomou, G.; Iconomou, A.V.; Argyriou, A.A.; Nikolopoulos, A.; Ifanti, A.A.; Kalofonos, H.P. 2008: Emotional distress in cancer patients at the beginning of chemotherapy and its relation to quality of life Journal of Buon: Official Journal of the Balkan Union of Oncology 13(2): 217-222
Qu, Q.; Shen, K.-w. 2012: Hepatitis B virus reactivation in patients receiving chemotherapy with breast cancer Zhonghua Yi Xue Za Zhi 92(34): 2377-2378
2012: Semuloparin helps prevent thromboembolic events in patients receiving chemotherapy Oncology 26(3): 258 264
Daniels, M.; Belt, R.J. 1982: High dose metoclopramide as an antiemetic for patients receiving chemotherapy with cis-platinum Oncology Nursing Forum 9(3): 20-22
Muhlradt, P.F.; Sasse, F. 1997: Epothilone B stabilizes microtubuli of macrophages like taxol without showing taxol-like endotoxin activity Cancer Research 57(16): 3344-3346
Clark, M.M.; Vickers, K.S.; Hathaway, J.C.; Smith, M.; Looker, S.A.; Petersen, L.R.; Pinto, B.M.; Rummans, T.A.; Loprinzi, C.L. 2007: Physical activity in patients with advanced-stage cancer actively receiving chemotherapy Journal of Supportive Oncology 5(10): 487-493
Pradermdee, P.; Manusirivithaya, S.; Tangjitgamol, S.; Thavaramara, T.; Sukwattana, P. 2006: Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy Journal of the Medical Association of Thailand 89(Suppl 4): S29-S36
Saisho, T.; Okusaka, T.; Ueno, H.; Morizane, C.; Okada, S. 2005: Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy Hepato-Gastroenterology 52(66): 1654-1658
Ozols, R.F. 2000: Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer Seminars in Oncology 27(3 Suppl 7: 3-7
Osoba, D.; Murray, N.; Gelmon, K.; Karsai, H.; Knowling, M.; Shah, A.; McLaughlin, M.; Fetherstonhaugh, E.; Page, R.; Bowman, C.A. 1994: Quality of life, appetite, and weight change in patients receiving dose-intensive chemotherapy Oncology 8(4): 61
Hatsuyama, T.; Umehara, K.; Wakamoto, A.; Sato, H. 2015: Study on the Antiemetic Effects of Aprepitant in Patients with Lung Cancer Receiving Chemotherapy with Carboplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(6): 725-729